Structures by: Shakhidoyatov K. M.
Total: 15
1-[(4-<i>tert</i>-Butylphenyl)sulfonyl]-1<i>H</i>-benzimidazole
C17H18N2O2S
Acta Crystallographica Section E (2011) 67, 3 o709
a=12.142(2)Å b=8.8940(18)Å c=15.324(3)Å
α=90.00° β=96.78(3)° γ=90.00°
1,3-Dibenzyl-1,2,3,4-tetrahydroquinazoline-2,4-dione
C22H18N2O2
Acta Crystallographica Section E (2010) 66, 7 o1547
a=17.8989(4)Å b=14.0071(4)Å c=27.7222(6)Å
α=90.00° β=90.00° γ=90.00°
2,3-gexamethylene-3,4-dihydroquinazolin-4-one
C14H16N2O
Acta Crystallographica Section E (2009) 65, 8 o1776
a=9.5490(19)Å b=10.584(2)Å c=11.693(2)Å
α=90.00° β=90.00° γ=90.00°
9-Furfurylidene-2,3-dimethyl-6,7,8,9-tetrahydro-4<i>H</i>-thieno[2',3':4,5]pyrimidino[1,2-<i>a</i>]pyridin-4-one
C17H16N2O2S
Acta Crystallographica Section E (2010) 66, 3 o552-o553
a=16.569(3)Å b=11.034(2)Å c=8.2775(17)Å
α=90.00° β=93.12(3)° γ=90.00°
11-(2-Oxopyrrolidin-1-ylmethyl)-1,2,3,4,5,6,11,11a-octahydropyrido[2,1-<i>b</i>]quinazolin-6-one dihydrate
C17H21N3O2,2(H2O)
Acta Crystallographica Section E (2010) 66, 4 o890
a=14.794(3)Å b=7.6720(15)Å c=15.593(3)Å
α=90.00° β=104.48(3)° γ=90.00°
(<i>E</i>)-3-Propoxymethylidene-2,3-dihydro-1<i>H</i>- pyrrolo[2,1-<i>b</i>]quinazolin-9-one monohydrate
C15H16N2O2,H2O
Acta Crystallographica Section E (2010) 66, 5 o1238
a=9.247(2)Å b=6.8760(10)Å c=10.950(2)Å
α=90.00° β=97.90(3)° γ=90.00°
(<i>E</i>)-3-[4-(Dimethylamino)benzylidene]-2,3-dihydro- 1<i>H</i>,9<i>H</i>-pyrrolo[2,1-<i>b</i>]quinazolin-9-one
C20H19N3O
Acta Crystallographica Section E (2010) 66, 7 o1592
a=8.8030(18)Å b=16.415(3)Å c=11.463(2)Å
α=90.00° β=105.05(3)° γ=90.00°
3-Benzyl-6-(2-chlorobenzoyl)-1,3-benzoxazol-2(3<i>H</i>)-one
C21H14ClNO3
Acta Crystallographica Section E (2010) 66, 12 o3203
a=13.391(7)Å b=7.317(6)Å c=18.611(9)Å
α=90.00° β=109.72(4)° γ=90.00°
2-Methyl-4-oxo-6,7,8,9-tetrahydrothieno[2',3':4,5]pyrimidino[1,2- <i>a</i>]pyridine-3-carboxylic acid
C12H12N2O3S
Acta Crystallographica Section E (2011) 67, 4 o824
a=7.2550(15)Å b=20.506(4)Å c=15.824(3)Å
α=90.00° β=96.93(3)° γ=90.00°
(4-Nitrophenyl)(1,2,3,9-tetrahydropyrrolo[2,1-<i>b</i>]quinazolin-3- yl)methanol monohydrate
C18H17N3O3,H2O
Acta Crystallographica Section E (2011) 67, 7 o1680
a=6.2459(7)Å b=11.4629(11)Å c=11.8400(13)Å
α=91.932(8)° β=95.589(9)° γ=104.747(9)°
Poly[di-μ-chlorido-μ-(1,2,3,9-tetrahydropyrrolo[2,1-<i>b</i>]quinazolin- 9-one-κ^2^<i>N</i>:<i>O</i>)-mercury(II)]
C11H10Cl2HgN2O
Acta Crystallographica Section E (2011) 67, 7 m953-m954
a=7.7275(11)Å b=9.4705(13)Å c=16.729(2)Å
α=90.00° β=101.416(2)° γ=90.00°
2,3-Dihydropyrrolo[2,1-<i>b</i>]quinazoline-9(1<i>H</i>)-thione
C11H10N2S
Acta Crystallographica Section E (2012) 68, 6 o1746
a=26.2060(10)Å b=26.2060(10)Å c=7.441(2)Å
α=90.00° β=90.00° γ=120.00°
3-Methyl-2-(3,3,3-trichloro-2-hydroxypropyl)quinazolin-4(3<i>H</i>)-one
C12H11Cl3N2O2
Acta Crystallographica Section E (2013) 69, 7 o1094
a=9.3440(19)Å b=11.352(2)Å c=25.719(5)Å
α=90.00° β=90.00° γ=90.00°
2,3-Dimethylquinazolin-4(3<i>H</i>)-one
C10H10N2O
Acta Crystallographica Section E (2014) 70, 7 o788
a=4.826(2)Å b=7.919(3)Å c=23.060(8)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(5-Benzylsulfanyl-1,3,4-thiadiazol-2-yl)-2-(piperidin-1-yl)acetamide
C16H20N4OS2
Acta Crystallographica Section E (2014) 70, 3 o241
a=17.429(4)Å b=16.748(3)Å c=5.8390(12)Å
α=90.00° β=95.48(3)° γ=90.00°